Sporadic Early Onset Colorectal Cancer in Pakistan: a Case-Control Analysis of Microsatellite Instability

  • Siddique, Sabeehuddin (Department of Pathology and Laboratory Medicine, Aga Khan University) ;
  • Tariq, Kanwal (Department of Biological and Biomedical Sciences, Aga Khan University) ;
  • Rafiq, Sobia (Department of Biological and Biomedical Sciences, Aga Khan University) ;
  • Raheem, Ahmed (Department of Pathology and Laboratory Medicine, Aga Khan University) ;
  • Ahmed, Rashida (Department of Pathology and Laboratory Medicine, Aga Khan University) ;
  • Shabbir-Moosajee, Munira (Department of Oncology, Aga Khan University) ;
  • Ghias, Kulsoom (Department of Biological and Biomedical Sciences, Aga Khan University)
  • Published : 2016.05.01


Background: Early onset sporadic colorectal cancer (CRC) is a biologically and clinically distinct entity hypothesized to exhibit differences in histological features and microsatellite instability (MSI) as compared to typical onset CRC. This study compared the MSI status, mismatch repair enzyme deficiency and clinicopathological features of early onset (aged ${\leq}45$ years) with controls (>45 years). Materials and Methods: A total of 30 cases and 30 controls were analyzed for MSI status using the Bethesda marker panel. Using antibodies against hMLH1, hMSH2 and hMSH6, mismatch repair protein expression was assessed by immunohistochemistry. Molecular characteristics were correlated with clinicopathological features. Results: The early onset sporadic CRCs were significantly more poorly differentiated tumors, with higher N2 nodal involvement and greater frequency of signet ring phenotype than the typical onset cases. MSI was observed in 18/30 cases, with 12/18 designated as MSI-high (MSI-H) and 6/18 designated as MSI-low (MSI-L). In the control group, 14 patients exhibited MSI, with 7 MSI-H and 7 MSI-L. MSI tumors in both cases and controls exhibited loss of hMLH1, hMSH2 and hMSH6. MSS tumors did not exhibit loss of expression of MMR proteins, except hMLH1 protein in 3 controls. No statistically significant difference was noted in MSI status or expression of MMR proteins in cases versus controls. Conclusions: Microsatellite status is comparable between early and typical onset sporadic CRC patients in Pakistan suggesting that differences in clinicopathological features between these two subsets are attributable to other molecular mechanisms.


Colorectal cancer;early onset;microsatellite instability;mismatch repair


Supported by : Aga Khan University


  1. Ahmed S, Banerjea A, Hands RE, Bustin S, Dorudi S (2005). Microarray profiling of colorectal cancer in Bangladeshi patients. Colorectal Dis, 7, 571-5.
  2. Albasri A, Yosef H, Hussainy AS, Sultan SA, Alhujaily A (2014). Histopathological features of colorectal cancer in Al-Madinah region of Saudi Arabia: 8 years experience. Asian Pac J Cancer Prev, 15, 3133-7.
  3. Al-Jaberi TM, Yaghan RJ, El-Heis HA (2003). Colorectal cancer in young patients under 40 years of age: Comparison with old patients in a well defined Jordanian population. Saudi Med J, 24, 871-4.
  4. Amini AQ, Samo KA, Memon AS (2013). Colorectal cancer in younger population: our experience. J Pak Med Assoc, 63, 1275-7.
  5. Andersen HS, Bertelsen CA, Henriksen R, et al (2016). The pathological phenotype of colon cancer with microsatellite instability. Dan Med J, 63, 5198.
  6. Barnetson RA, Tenesa A, Farrington SM, et al (2006). Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med, 354, 2751-63.
  7. Bhurgri Y, Khan T, Kayani N, et al (2011). Incidence and current trends of colorectal malignancies in an unscreened, low risk Pakistan population. Asian Pac J Cancer Prev, 12, 703-8.
  8. Boland CR, Thibodeau SN, Hamilton SR, et al (1998). A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res, 58, 5248-5257.
  9. Boland CR (2005). Evolution of the nomenclature for the hereditary colorectal cancer syndromes. Fam Cancer, 4, 211-8.
  10. Center MM, Jemal A, Ward E (2009). International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prevent, 18, 1688-94.
  11. Cheah P-L, Looi L-M, Teoh K-H, et al (2014). Colorectal carcinoma in Malaysians: DNA mismatch repair pattern in a multiethnic population. Asian Pac J Cancer Prev, 15, 3287-91.
  12. Chew M-H, Koh P-K, Ng K-H, Eu K-W (2009). Improved survival in an Asian cohort of young colorectal cancer patients: an analysis of 523 patients from a single institution. Int J Colorectal Dis, 24, 1075-83.
  13. Chiang J-M, Chen M-C, Changchien CR, et al (2003). Favorable influence of age on tumor characteristics of sporadic colorectal adenocarcinoma: patients 30 years of age or younger may be a distinct patient group. Dis Colon Rectum, 46, 904-910.
  14. Dieumegard B, Grandjouan S, Sabourin JC, et al (2000). Extensive molecular screening for hereditary non-polyposis colorectal cancer. Br J Cancer, 82, 871-880.
  15. El-Hennawy MM, Moussa M-E, El-Saeidy MK, et al (2003). Rectal carcinoma in Egyptian patients less than 40 years of age. Int Surg, 88, 137-44.
  16. Ferlay J, Soerjomataram I, Dikshit R, et al (2015). Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 136, 359-86.
  17. Gatalica Z, Vranic S, Xiu J, Swensen J, Reddy S (2016). High microsatellite instability (MSI-H) colorectal carcinoma: a brief review of predictive biomarkers in the era of personalized medicine. Fam Cancer, 1-8.
  18. Gill S, Lindor NM, Burgart LJ, et al (2005). Isolated loss of PMS2 expression in colorectal cancers: frequency, patient age, and familial aggregation. Clin Cancer Res, 11, 6466-71.
  19. Giraldez MD, Balaguer F, Bujanda L, et al (2010). MSH6 and MUTYH deficiency is a frequent event in early-onset colorectal cancer. Clin Cancer Res, 16, 5402-13.
  20. Gryfe R, Kim H, Hsieh ET, et al (2000). Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med, 342, 69-77.
  21. Gupta S, Bhattacharya D, Acharya AN, et al (2010). Colorectal carcinoma in young adults: a retrospective study on Indian patients: 2000-2008. Colorectal Dis, 12, 182-9.
  22. Guraya SY, Eltinay OE (2006). Higher prevalence in young population and rightward shift of colorectal carcinoma. Saudi Med J, 27, 1391-3.
  23. Haggar FA, Boushey RP (2009). Colorectal cancer epidemiology: Incidence, mortality, survival, and risk Factors. Clin Colon Rectal Surg, 22, 191-197.
  24. Hendriks Y, Franken P, Dierssen JW, et al (2003). Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors. Am J Pathol, 162, 469-477.
  25. Herman JG, Umar A, Polyak K, et al (1998). Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. P Natl Acad Sci USA, 95, 6870-6875.
  26. Jemal A, Siegel R, Xu J, Ward E (2010). Cancer statistics, 2010. CA Cancer J Clin, 60, 277-300.
  27. Kanth VV, Bhalsing S, Sasikala M, et al (2014). Microsatellite instability and promoter hypermethylation in colorectal cancer in India. Tumour Biol, 35, 4347-55.
  28. Karahan B, Argon A, Yildirim M, Vardar E (2015). Relationship between MLH-1, MSH-2, PMS-2, MSH-6 expression and clinicopathological features in colorectal cancer. Int J Clin Exp Pathol, 8, 4044-53.
  29. Liang JT, Huang KC, Cheng AL, et al (2003). Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of age. Br J Surg, 90, 205-14.
  30. Magnani G, Furlan D, Sahnane N, et al (2015). Molecular features and methylation status in early onset (${\leq}40$ years) colorectal cancer: a population based, case-control study. Gastroenterol Res Pract, 2015.
  31. Michailidi C, Papavassiliou AG, Troungos C (2012). DNA repair mechanisms in colorectal carcinogenesis. Curr Mol Med, 12, 237-246.
  32. Moghbeli M, Moaven O, Dadkhah E, et al (2011). High frequency of microsatellite instability in sporadic colorectal cancer patients in Iran. Genet Mol Res, 10, 3520-9.
  33. Mojtahed A, Schrijver I, Ford JM, Longacre TA, Pai RK (2011). A two-antibody mismatch repair protein immunohistochemistry screening approach for colorectal carcinomas, skin sebaceous tumors, and gynecologic tract carcinomas. Mod Pathol, 24, 1004-14.
  34. Muller W, Burgart LJ, Krause-Paulus R, et al (2001). The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC): results of an international collaborative study. Fam Cancer, 1, 87-92.
  35. Musulen E, Sanz C, Munoz-Marmol AM, Ariza A (2014). Mismatch repair protein immunohistochemistry: a useful population screening strategy for Lynch syndrome. Hum Pathol, 45, 1388-96.
  36. Niessen RC, Berends MJW, Wu Y, et al (2006). Identification of mismatch repair gene mutations in young patients with colorectal cancer and in patients with multiple tumours associated with hereditary non-polyposis colorectal cancer. Gut, 55, 1781-8.
  37. O'Connell JB, Maggard MA, Livingston EH, et al (2004). Colorectal cancer in the young. Am J Surg, 187, 343-8.
  38. Peltomaki P (2005). Lynch syndrome genes. Fam Cancer, 4, 227-32.
  39. Perea J, Alvaro E, Rodriguez Y, et al (2010). Approach to early-onset colorectal cancer: Clinicopathological, familial, molecular and immunohistochemical characteristics. World J Gastroenterol, 16, 3697-703.
  40. Phipps AI, Limburg PJ, Baron JA, et al (2015). Association between molecular subtypes of colorectal cancer and patient survival. Gastroenterol, 148, 77-87.
  41. Pikor LA, Enfield KSS, Cameron H, Lam WL (2011). DNA extraction from paraffin embedded material for genetic and epigenetic analyses. J Vis Exp, 49, 2763.
  42. Raman R, Kotapalli V, Adduri R, et al (2014). Evidence for possible non-canonical pathway(s) driven early-onset colorectal cancer in India. Mol Carcinog, 53, 181-6.
  43. Saridaki Z, Souglakos J, Georgoulias V (2014). Prognostic and predictive significance of MSI in stages II/III colon cancer. World J Gastroenterol, 20, 6809-14.
  44. Sekal M, Ameurtesse H, Chbani L, et al (2015). Epigenetics could explain some Moroccan population colorectal cancers peculiarities: microsatellite instability pathway exploration. Diagnostic Pathol, 10, 77.
  45. Shemesh-Bar L, Kundel Y, Idelevich E, et al (2010). Colorectal cancer in young patients in Israel: a distinct clinicopathological entity? World J Surg, 34, 2701-9.
  46. Shia J, Klimstra DS, Nafa K, et al (2005). Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms. Am J Surg Pathol, 29, 96-104.
  47. Shia J (2008). Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. J Mol Diagn, 10, 293-300.
  48. Singh Y, Vaidya P, Hemandas AK, Singh KP, Khakurel M (2002). Colorectal carcinoma in Nepalese young adults: presentation and outcome. Cancer Chemotherapy, 29, 223-9.
  49. Veigl ML, Kasturi L, Olechnowicz J, et al (1998). Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. P Natl Acad Sci USA, 95, 8698-8702.
  50. Whitehall V, Leggett B (2011). Microsatellite instability: detection and management in sporadic colorectal cancer. J Gastroen Hepatol, 26, 1697-9.
  51. Yoon YS, Yu CS, Kim TW, et al (2011). Mismatch repair status in sporadic colorectal cancer: Immunohistochemistry and microsatellite instability analyses. J Gastroen Hepatol, 26, 1733-9.
  52. Zahir MN, Azhar EM, Rafiq S, et al (2014). Clinical features and outcome of sporadic colorectal carcinoma in young patients: a cross-sectional analysis from a developing country. ISRN Oncol, 2014, 461570.
  53. Ziadi S, Ksiaa F, Gacem RB, et al (2014). Clinicopathologic characteristics of colorectal cancer with microsatellite instability. Pathol Res Pract, 210, 98-104.